Direct radiolabeling of monoclonal antibodies with rhenium-188 for radioimmunotherapy of solid tumors — a review of radiolabeling characteristics, quality control and in vitro stability studies
- 8 February 2001
- journal article
- review article
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 54 (3) , 399-406
- https://doi.org/10.1016/s0969-8043(00)00277-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The role of tin in the direct labelling of proteins with rhenium-188Nuclear Medicine and Biology, 1997
- Targeting Peptides for Pleural Cavity Tumor Radiotherapy: Specificity and Dosimetry of Re-188-RC-160Hybridoma, 1997
- Purification by Affinity Chromatography with Anti-idiotypic Monoclonal Antibodies of Immunoreactive Monoclonal Antibodies Following Labeling with 188ReHybridoma, 1997
- Re-188 labelled antibodiesApplied Radiation and Isotopes, 1996
- Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac [see comments]Blood, 1995
- Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?Nuclear Medicine and Biology, 1994
- Technetium-99m, rhenium-186, and rhenium-188 direct-labeled antibodiesCancer, 1994
- Radiolabeling of monoclonal antibodies and fragments with technetium and rheniumBioconjugate Chemistry, 1992
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975